Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01436240 · ClinicalTrials.gov registry record
Spanish Translation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 112
- Enrollment target
NCT01436240: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01436240 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 112 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01436240 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 112 participants
- Enrollment target
Study Summary
The purpose of this study is to see if questions in English about symptoms that patients may have during cancer treatment are understandable when translated into Spanish. These questions will later be used in future studies to give a better understanding of patient symptoms".
Interventions
- BEHAVIORAL questionnaire administration followed by cognitive interviews
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2011-09 |
| Est. Completion | 2017-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01436240
The ClinicalTrials.gov registry entry for NCT01436240 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which questionnaire administration followed by cognitive interviews is the first listed.
NCT01436240 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01436240 about?
NCT01436240 is a clinical study titled "Spanish Translation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)". The purpose of this study is to see if questions in English about symptoms that patients may have during cancer treatment are understandable when translated into Spanish. These questions will later be used in future studies to give a better understanding of patient symptoms".
What is the current status of trial NCT01436240?
This trial is currently completed. The enrollment target is 112 participants. The study started on 2011-09. Estimated completion is 2017-05.
What interventions are being tested in trial NCT01436240?
The interventions under investigation include: questionnaire administration followed by cognitive interviews (BEHAVIORAL).
Who is sponsoring clinical trial NCT01436240?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.